Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARILUMAB vs SATRALIZUMAB-MWGE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARILUMAB vs SATRALIZUMAB-MWGE: Safety Overview

Metric SARILUMAB SATRALIZUMAB-MWGE
Total FAERS Reports 21,493 1,112
Deaths Reported 1,983 54
Death Rate 9.2% 4.9%
Hospitalizations 3,538 398
Average Patient Age 57.5 yrs 56.3 yrs
% Female Patients 84.4% 86.4%
Manufacturer Sanofi-Aventis U.S. LLC N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A